Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Cellsway logo — Liquid biopsy for cancer monitoring through isolation and co...

Cellsway

Liquid biopsy for cancer monitoring through isolation and counting Circulating Tumor Cells (CTCs) from blood.

Founded 2020 United Kingdom Ankara, United Kingdom 5 employees Total: $1.45M Biotechnology, Health Care

General Information

Company Name Cellsway
Founded Year 2020
Location United Kingdom Ankara, United Kingdom
Founders / Decision Makers
Team member
Employees 5
Industries Biotechnology, Health Care
Business Model B2B, D2C, B2D
Revenue Model Product Sales, Service Fee, Usage Based
Offices as of Oct 2026
Cheshire, United Kingdom
Social

BounceWatch is an independent company data service, not affiliated with Cellsway. To contact Cellsway, visit cellsway.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cellsway compare?

A PDF of Cellsway and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cellsway soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

New Partnership Oct 29, 2026

Cellsway announced a 3-year clinical study partnership with the TÜSEB Turkish Cancer Institute.

Get alerts when Cellsway shows new signals

About Cellsway

Cellsway, a deep-tech start-up, is making strides in the Biotechnology and Health Care industries with its innovative approach to cancer monitoring. Founded in 2020 in the United Kingdom, this company aims to revolutionize cancer diagnostics through its flagship product: a liquid biopsy platform.

The company's technology focuses on isolating and counting Circulating Tumor Cells (CTCs) using patent-pending microfluidic technology. By utilizing a simple blood sample, it offers a non-invasive method for cancer diagnostics and research, setting a new standard in the field.

Most recently, Cellsway secured a €1.00M early VC investment on 01 August 2024 from the Turkish Development Fund, signifying strong investor confidence in their potential. This financial backing supports their mission to transform cutting-edge technology into commercial solutions, potentially reshaping how cancer is diagnosed and managed globally.

Business keywords: Liquid Biopsy, Cancer Monitoring, Circulating Tumor Cells, CTC Detection, Microfluidics, Lab-on-a-chip, Biomedical Technology, Cancer Diagnostics, Cancer Research, Minimally Invasive Technology, Blood Sample Analysis, Deep-tech Startup, Oncology, Precision Medicine, Patent-pending Technology

Services & Products

CTC Enrichment Device
CTC Identification Panel
ER/PR/Her2 CTC Panel
PD-L1 CTC Panel

Target Customers

Cancer Patients Oncologists Clinical Laboratories Research Institutions

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC €1.00M 1
Turkish Development Fund
01 Aug 2024
Grant €200.00K 1
APY Ventures
APY Ventures
01 Oct 2023
Convertible Note $100.00K -
01 Jul 2023
Convertible Note $150.00K 1
Teknoloji Yatirim A.S.
Teknoloji Yatirim A.S.
01 Aug 2022
Convertible Note Undisclosed 1
Growth Circuit
Growth Circuit
01 Dec 2021

Latest News

View All
Sağlık teknolojilerine odaklanan Cellsway, Teknoloji ve İnovasyon Fonu'ndan yatırım aldı — Webrazzi
Sağlık teknolojilerine odaklanan Cellsway, Teknoloji ve İnovasyon Fonu'ndan yatırım aldı
Webrazzi Aug 22, 2024
Sağlık teknolojileri geliştiren Cellsway, APY Ventures’tan 200 bin euro yatırım aldı — Webrazzi
Sağlık teknolojileri geliştiren Cellsway, APY Ventures’tan 200 bin euro yatırım aldı
Webrazzi Jan 23, 2024

Cellsway Alternatives & Competitors

View All Alternatives
Cellsway vs
Vortex Biosciences
Vortex Biosciences United States

Circulating Tumor Cells (CTCs) are cancer cells, which have detached from the primary tumor and have...

Venture round
7 employees
Biotechnology, Health Care
Cellsway vs
ANGLE
ANGLE United Kingdom

The leading experts in cancer cell capture and analysis from liquid biopsies

Post-IPO Equity
165 employees
Biotechnology, Health Care
Cellsway vs
NVIGEN Inc.
NVIGEN Inc. United States

Molecularly Engineered Nanoparticles to Advance Personalized Medicine

Series B
11 employees
Biotechnology, Health Care
View all alternatives

FAQ About Cellsway

Liquid biopsy for cancer monitoring through isolation and counting Circulating Tumor Cells (CTCs) from blood.
Cellsway was founded in 2020.
Cellsway is headquartered in Ankara, United Kingdom. As of Oct 2026, it also has offices in Cheshire, United Kingdom.
Cellsway operates in Biotechnology and Health Care. Its work centres on Liquid Biopsy, Cancer Monitoring, Circulating Tumor Cells and CTC Detection. Its customers include Cancer Patients, Oncologists and Clinical Laboratories.
Cellsway has a B2B, D2C and B2D business model. Its revenue comes from Product Sales, Service Fee and Usage Based.
Cellsway has approximately 5 employees.
Cellsway has completed 5 funding rounds, raising a total of $1.45M.
Cellsway offers: CTC Enrichment Device, CTC Identification Panel, ER/PR/Her2 CTC Panel, PD-L1 CTC Panel.
Top alternatives and competitors to Cellsway include Vortex Biosciences, ANGLE, NVIGEN Inc., Capio Biosciences, Exai Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cellsway and Vortex Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cellsway, https://bouncewatch.com/company/cellsway, updated 2 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes